Genetic tests for cancer can run thousands of dollars, but Color Genomics plans to change that: it's offering testing for the cancer risk variants BRCA1 and BRCA2 — as well as 17 others — for $249, ...

Color, a population genomics and healthcare technology company that counts Apple, Verily and, most recently, Sioux Falls, S.D.-based Sanford Health among its partners, has closed a $75 million funding ...

A test in the Triad that can tell if you have an increased chance of breast cancer, ovarian cancer, colon cancer and heart ...

When a patient has an inherited cancer-associated gene, it is desirable — but not easy — to have other family members tested. In the United States, the difficulty primarily stems from privacy ...

Colorectal cancer is officially the leading cause of cancer-related death among younger men, according to a January report by the American Cancer Society. It is also the second leading cause for women ...